2017
DOI: 10.1016/j.actbio.2016.10.032
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradable and biomimetic elastomeric scaffolds for tissue-engineered heart valves

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
61
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 69 publications
(62 citation statements)
references
References 162 publications
0
61
0
Order By: Relevance
“…The hard segments are built from diisocyanates and short chain extenders, whereas soft segments are derived from polyols [4,5]. Another interesting feature is the microphase separation of hard and soft segments that significantly influence the properties of PU [6]. Typical chain extenders in PU synthesis are low-molecular-weight diols (HO-R-OH), such as 1,4-butanediol, diethylene glycol, ethylene glycol and 1,6-hexanediol, or diamines (NH 2 -R-NH 2 ), like 1,6-hexamethylenediamine and 1,2-ethylenediamine [2,7].…”
Section: Introductionmentioning
confidence: 99%
“…The hard segments are built from diisocyanates and short chain extenders, whereas soft segments are derived from polyols [4,5]. Another interesting feature is the microphase separation of hard and soft segments that significantly influence the properties of PU [6]. Typical chain extenders in PU synthesis are low-molecular-weight diols (HO-R-OH), such as 1,4-butanediol, diethylene glycol, ethylene glycol and 1,6-hexanediol, or diamines (NH 2 -R-NH 2 ), like 1,6-hexamethylenediamine and 1,2-ethylenediamine [2,7].…”
Section: Introductionmentioning
confidence: 99%
“…An ideal tissue-engineering material needs to have the mechanical properties similar to the natural tissue material. Compared with the native tissue regeneration process, the material should be biocompatible and biodegradable [1,2]. Synthesis of a novel biodegradable and biocompatible polyurethane material is important for biomedical engineering applications.…”
Section: Introductionmentioning
confidence: 99%
“…In order to facilitate the potential translation of CNP treatment for valve calcification therapy, we envision that the local delivery of CNPs via a tissue-engineered construct 4 or polymeric drug carrier 57 will minimize the systemic exposure and prevent the calcification of valve replacement.…”
Section: Study Limitations and Outlookmentioning
confidence: 99%
“…2 Currently, the mainstream treatment option for valve calcification is valve replacement using either mechanical valves or bioprostheses, the former requires life-long anticoagulant therapy and the latter is still unfortunately susceptible to calcification and also need re-operation. 3,4 …”
Section: Introductionmentioning
confidence: 99%